Curated gurus reporting this holding
A curated subset of well-known investors — not the full institutional ownership.
- Bridgewater Associates248,575주2026-06-30 · 증감 -2931주
Harmony Biosciences Hldg company information
하모니 바이오사이언시스 홀딩스NASDAQ:HRMY · Nasdaq · Healthcare · sector #13$39.92+0.71%
2026-10-05 closeHarmony Biosciences Hldg's company information is shown as of 2026-10-05. It is a security listed on Nasdaq, ticker HRMY. There are 10 published related companies.
About this company
Harmony Biosciences Hldg last closed at $39.92 (+0.71%) on 2026-10-05. Signals today: VCP. Listed on Nasdaq.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F is quarterly and may be filed up to 45 days later.
Suppliers, competitors and related stocks
- Jazz PharmaceuticalsCompetitor
듀피노시티/수면질환 등 신경·희귀질환 영역에서 경쟁
- Takeda PharmaceuticalCompetitor
과다졸음증·희귀질환 파이프라인 및 상용 약물 경쟁
- Avadel PharmaceuticalsCompetitor
기면증 치료제 시장에서 직접 경쟁
- Bioprojet PharmaSupplier
피톨리산트(wakix) 관련 원천기술/지식재산과 연관된 핵심 파트너
- XywavCompetitor
기면증 치료 시장의 핵심 경쟁 제품
- WakixRelated theme
Harmony Biosciences의 핵심 매출 품목인 기면증 치료제
- NarcolepsyRelated theme
회사의 주력 치료 영역인 수면질환 테마
- Idiopathic HypersomniaRelated theme
확장 중인 주요 타깃 질환 테마
- Prader-Willi SyndromeRelated theme
중추신경계 희귀질환 개발 포트폴리오 테마
- Alzheimer's diseaseRelated theme
후기 임상/확장 파이프라인에서 주목받는 적응증 테마
Major stocks in the same sector
2026-10-06 dataset
📦 ETFs holding this stock
by weight · top-10 constituents basisPassive money holding this stock ≈ $1M(lower bound — top-10 basis, not a forecast)
Factual holdings info from daily disclosures — not a recommendation.
Look up another stock →Quantus Signal · live data · not investment advice · Privacy Policy